Tax Management India. Com
Law and Practice  :  Digital eBook
Research is most exciting & rewarding
  TMI - Tax Management India. Com
Follow us:
  Facebook   Twitter   Linkedin   Telegram

Home Case Index All Cases Central Excise Central Excise + AT Central Excise - 2022 (4) TMI AT This

  • Login
  • Cases Cited
  • Summary

Forgot password       New User/ Regiser

⇒ Register to get Live Demo



 

2022 (4) TMI 1358 - AT - Central Excise


Issues Involved:
1. Eligibility for exemption under Notification No. 8/2003-CE.
2. Invocation of extended period for demand.
3. Justification of penalties imposed.
4. Eligibility for cum-duty benefit.

Issue-wise Detailed Analysis:

1. Eligibility for Exemption under Notification No. 8/2003-CE:
The primary issue was whether the appellants (M/s Dr. Smita Herbal Laboratories) could avail the exemption under Notification No. 8/2003-CE for products bearing the brand names "Cureon," "Vasundhara," and "Healmate," assigned to them by M/s Pitambari Products Pvt. Ltd. (M/s PPPL). The appellants argued that the brands were assigned to them through deeds of assignment and that M/s PPPL did not manufacture the specified products during the impugned period. However, the Tribunal found that the ownership of the brand names remained with M/s PPPL, and the appellants were merely manufacturing the goods using these brands. The Tribunal concluded that the appellants were not eligible for the exemption as the goods were associated with M/s PPPL, and the notification did not provide scope for benefit on assignment.

2. Invocation of Extended Period for Demand:
The appellants contended that they had a bona fide belief that they were eligible for the exemption, and therefore, the extended period for demand should not be invoked. The Department argued that the appellants did not file periodic returns, making it difficult to detect the violation. The Tribunal found that the appellants could not claim bona fide belief due to the clear wording of the notification and the established legal precedents. Consequently, the extended period was rightly invoked.

3. Justification of Penalties Imposed:
The penalties imposed on the appellants and their directors were considered harsh. The Tribunal reduced the penalties imposed on Dr. Smita Raste and Shantanu Raste, considering their roles in the case. However, the penalty on M/s PPPL was set aside as their role in the evasion of duty was not clearly established. The Tribunal held that M/s PPPL's assignment of brand names to the appellants did not make them liable for the appellants' duty evasion.

4. Eligibility for Cum-duty Benefit:
The appellants argued that the adjudicating authority did not allow cum-duty benefit. The Tribunal found merit in this submission and directed that the duty liability should be recalculated after allowing cum-duty benefit. The interest and penalty would be based on the recalculated duty.

Order:
1. Appeals E/392/2011 and E/86417/2017 were partly allowed by remanding to the original authority to recalculate duty after allowing cum-duty benefit.
2. Penalties on Dr. Smita Raste were reduced to ?5,00,000/- and ?1,00,000/- respectively.
3. Penalties on Shantanu Raste were reduced to ?1,00,000/- and ?10,000/- respectively.
4. Appeals E/395/2011 and E/86416/2017 were allowed, setting aside the penalty on M/s PPPL.

Conclusion:
The Tribunal concluded that the appellants were not eligible for the exemption under Notification No. 8/2003-CE, the extended period for demand was applicable, and penalties were adjusted based on the roles of the individuals involved. Cum-duty benefit was allowed, and the duty liability was to be recalculated accordingly.

 

 

 

 

Quick Updates:Latest Updates